Search hospitals > California > Fresno
Neuro Pain Medical Center
Claim this profileFresno, California 93710
Global Leader in Alzheimer's Disease
Global Leader in Migraine
Conducts research for Epilepsy
Conducts research for Seizures
Conducts research for Parkinson's Disease
65 reported clinical trials
1 medical researcher
Summary
Neuro Pain Medical Center is a medical facility located in Fresno, California. This center is recognized for care of Alzheimer's Disease, Migraine, Epilepsy, Seizures, Parkinson's Disease and other specialties. Neuro Pain Medical Center is involved with conducting 65 clinical trials across 48 conditions. There are 1 research doctors associated with this hospital, such as Perminder J Bhatia.Area of expertise
1Alzheimer's Disease
Global LeaderApoE positive
ApoE negative
2Migraine
Global LeaderTop PIs
Clinical Trials running at Neuro Pain Medical Center
Migraine
Alzheimer's Disease
Epilepsy
Seizures
Alzheimer's Dementia
Dementia
Focal Seizures
Muscle Spasms
Upper Limb Spasticity
Generalized Epilepsy
Atogepant + Botox
for Chronic Migraine
This trial is testing a new daily pill called atogepant, used along with regular BOTOX treatments, to help prevent migraines. It targets adults who suffer from frequent and severe headaches. The pill works by blocking certain brain signals that trigger migraines. The study will monitor safety, side effects, and effectiveness over several months. Atogepant is a newly approved medication for the prevention of migraine.
Recruiting2 awards Phase 33 criteria
Rimegepant
for Pediatric Migraine
This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.
Recruiting2 awards Phase 38 criteria
Ubrogepant
for Migraine
A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 450 adult female participants with menstrual migraine will be enrolled in approximately 85 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Neuro Pain Medical Center?
Neuro Pain Medical Center is a medical facility located in Fresno, California. This center is recognized for care of Alzheimer's Disease, Migraine, Epilepsy, Seizures, Parkinson's Disease and other specialties. Neuro Pain Medical Center is involved with conducting 65 clinical trials across 48 conditions. There are 1 research doctors associated with this hospital, such as Perminder J Bhatia.